Literature DB >> 11807011

Activation of 5-lipoxygenase by cell stress is calcium independent in human polymorphonuclear leukocytes.

Oliver Werz1, Eva Bürkert, Bengt Samuelsson, Olof Rådmark, Dieter Steinhilber.   

Abstract

5-Lipoxygenase (5-LO) is the key enzyme in the biosynthesis of proinflammatory leukotrienes. This study showed that various forms of cell stress, such as chemical stress (sodium arsenite), osmotic stress, or heat shock lead to substantial formation of 5-LO products in freshly isolated human polymorphonuclear leukocytes (PMNLs), when exogenous arachidonic acid (10 microM) was present. In parallel, cell stress led to activation of p38 MAPK (mitogen-activated protein kinase) and mitogen-activated protein kinase-activated protein kinases (MAPKAPKs) kinases, which can phosphorylate 5-LO in vitro. Interestingly, arsenite also caused redistribution of 5-LO from the cytosol to the nuclear membrane. Only minor activation of extracellular signal-regulated kinases and c-jun NH(2)-terminal kinases was observed, implying that these MAPKs are less important for 5-LO product formation in stress-stimulated PMNLs. Stimulation of 5-LO product formation by Ca(++)-ionophore A23187 or thapsigargin depended on Ca(++); almost no 5-LO product formation was observed in freshly isolated PMNLs when Ca(++) was depleted by chelating agents. Also the response to N-formylmethionyl-leucyl-phenylalanine (fMLP) was clearly diminished, but some 5-LO product formation remained. In contrast, stress-induced product formation and translocation of 5-LO, as well as activation of p38 MAPK, occurred also after Ca(++) depletion. Moreover, the p38 MAPK inhibitor SB203580 blocked stress-induced 5-LO product formation efficiently, whereas ionophore- or thapsigargin-induced formation of 5-LO products was less sensitive. These data show that cell stress can activate 5-LO in isolated PMNLs by a mechanism that does not involve Ca(++) mobilization. This mechanism could function independently of Ca(++)-mediated 5-LO activation for stimulation of leukotriene biosynthesis under physiologic conditions as well as in inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11807011     DOI: 10.1182/blood.v99.3.1044

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  26 in total

1.  Molecular pharmacological profile of a novel thiazolinone-based direct and selective 5-lipoxygenase inhibitor.

Authors:  B Hofmann; C B Rödl; A S Kahnt; T J Maier; A A Michel; M Hoffmann; O Rau; K Awwad; M Pellowska; M Wurglics; M Wacker; A Zivković; I Fleming; M Schubert-Zsilavecz; H Stark; G Schneider; D Steinhilber
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

2.  Electrophilic fatty acid species inhibit 5-lipoxygenase and attenuate sepsis-induced pulmonary inflammation.

Authors:  Khader Awwad; Svenja D Steinbrink; Timo Frömel; Nicole Lill; Johann Isaak; Ann-Kathrin Häfner; Jessica Roos; Bettina Hofmann; Heinrich Heide; Gerd Geisslinger; Dieter Steinhilber; Bruce A Freeman; Thorsten J Maier; Ingrid Fleming
Journal:  Antioxid Redox Signal       Date:  2014-02-03       Impact factor: 8.401

3.  5-Lipoxygenase: mechanisms of regulation.

Authors:  Olof Rådmark; Bengt Samuelsson
Journal:  J Lipid Res       Date:  2008-11-05       Impact factor: 5.922

4.  Pharmacophore modeling and virtual screening for novel acidic inhibitors of microsomal prostaglandin E₂ synthase-1 (mPGES-1).

Authors:  Birgit Waltenberger; Katja Wiechmann; Julia Bauer; Patrick Markt; Stefan M Noha; Gerhard Wolber; Judith M Rollinger; Oliver Werz; Daniela Schuster; Hermann Stuppner
Journal:  J Med Chem       Date:  2011-04-20       Impact factor: 7.446

5.  Phospholipid Ozonation Products Activate the 5-Lipoxygenase Pathway in Macrophages.

Authors:  Karin A Zemski Berry; Robert C Murphy
Journal:  Chem Res Toxicol       Date:  2016-08-03       Impact factor: 3.739

6.  Molecular pharmacological profile of the nonredox-type 5-lipoxygenase inhibitor CJ-13,610.

Authors:  Lutz Fischer; Dieter Steinhilber; Oliver Werz
Journal:  Br J Pharmacol       Date:  2004-06-14       Impact factor: 8.739

7.  Characterization of the endocannabinoid system in human neuronal cells and proteomic analysis of anandamide-induced apoptosis.

Authors:  Nicoletta Pasquariello; Giuseppina Catanzaro; Valeria Marzano; Daniele Amadio; Daniela Barcaroli; Sergio Oddi; Giorgio Federici; Andrea Urbani; Alessandro Finazzi Agrò; Mauro Maccarrone
Journal:  J Biol Chem       Date:  2009-08-18       Impact factor: 5.157

8.  Hyperforin is a novel type of 5-lipoxygenase inhibitor with high efficacy in vivo.

Authors:  Christian Feisst; Carlo Pergola; Marija Rakonjac; Antonietta Rossi; Andreas Koeberle; Gabriele Dodt; Marika Hoffmann; Christina Hoernig; Lutz Fischer; Dieter Steinhilber; Lutz Franke; Gisbert Schneider; Olof Rådmark; Lidia Sautebin; Oliver Werz
Journal:  Cell Mol Life Sci       Date:  2009-07-05       Impact factor: 9.261

9.  Involvement of Toso in activation of monocytes, macrophages, and granulocytes.

Authors:  Karl S Lang; Philipp A Lang; Andreas Meryk; Aleksandra A Pandyra; Louis-Martin Boucher; Vitaly I Pozdeev; Michael W Tusche; Joachim R Göthert; Jillian Haight; Andrew Wakeham; Annick J You-Ten; David R McIlwain; Katja Merches; Vishal Khairnar; Mike Recher; Garry P Nolan; Yasumichi Hitoshi; Pauline Funkner; Alexander A Navarini; Admar Verschoor; Namir Shaabani; Nadine Honke; Linda Z Penn; Pamela S Ohashi; Dieter Häussinger; Kyeong-Hee Lee; Tak W Mak
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-28       Impact factor: 11.205

10.  Sulindac sulfide suppresses 5-lipoxygenase at clinically relevant concentrations.

Authors:  Svenja D Steinbrink; Carlo Pergola; Ulrike Bühring; Sven George; Julia Metzner; Astrid S Fischer; Ann-Kathrin Häfner; Joanna M Wisniewska; Gerd Geisslinger; Oliver Werz; Dieter Steinhilber; Thorsten J Maier
Journal:  Cell Mol Life Sci       Date:  2009-11-29       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.